{"title":"Hemodialysis and minerals in end stage renal disease","authors":"Elcy Tufenkjy, Raghda Lahdo","doi":"10.1016/j.cca.2025.120485","DOIUrl":null,"url":null,"abstract":"<div><h3>Background-aim</h3><div>Hemodialysis is the most common reliable therapy of renal replacement in Kidney Disease, especially, the end stage renal disease (ESRD), characterized with the complete loss of kidney function, including excretion of wastes and fluids, control of blood acid-base and mineral concentrations. During hemodialysis, kidney roles are restored, by the balance of substances between the dialysis fluid and patients’ blood. However, it may cause serious disturbances of some minerals concentrations in patients’ blood, like (Zn, Cu, Mg, etc.), if hemodialysis conditions weren’t suitable. This review will discuss this major problem that may lead to life threatening complications in ESRD patients, like: cancer, cardiovascular disease, and worsening of kidney function.</div></div><div><h3>Methods</h3><div>A literature review was done, comparing the results of several previous studies published in international scientific journals, about mineral disturbances in ESRD patients undergoing hemodialysis, among different countries in the world. In all mentioned studies blood samples were taken from patients pre and post dialysis, measuring minerals by atomic absorption spectroscopy.</div></div><div><h3>Results</h3><div>The included studies obtained conflicting results, as some of them showed an increase in some minerals levels in post dialysis patients compared to pre dialysis, like (Zn, Cr), while other studies revealed a decrease in minerals post dialysis, like Mg, whereas, others found no significant differences between pre and post dialysis, like (Cu, Se). This contradiction may be due to the country of the study, environmental pollution, nutritional conditions, as well as, the conditions of hemodialysis, such as the composition of dialysis fluid, which is affected by the source of its water, and its content of minerals. The type of used dialysis membrane and its surface area also have effect on the movement of minerals through it, between the blood and the dialysis fluid.</div></div><div><h3>Conclusion</h3><div>In order to avoid the disturbances in serum minerals concentrations in ESRD patients, they should be regularly measured pre and post dialysis, doing the appropriate therapeutic procedures, in addition to best controlling of hemodialysis conditions, especially, the mineral content of hemodialysis fluid, in order to keep their balance in patients’ blood.</div></div>","PeriodicalId":10205,"journal":{"name":"Clinica Chimica Acta","volume":"577 ","pages":"Article 120485"},"PeriodicalIF":2.9000,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Chimica Acta","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S000989812500364X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background-aim
Hemodialysis is the most common reliable therapy of renal replacement in Kidney Disease, especially, the end stage renal disease (ESRD), characterized with the complete loss of kidney function, including excretion of wastes and fluids, control of blood acid-base and mineral concentrations. During hemodialysis, kidney roles are restored, by the balance of substances between the dialysis fluid and patients’ blood. However, it may cause serious disturbances of some minerals concentrations in patients’ blood, like (Zn, Cu, Mg, etc.), if hemodialysis conditions weren’t suitable. This review will discuss this major problem that may lead to life threatening complications in ESRD patients, like: cancer, cardiovascular disease, and worsening of kidney function.
Methods
A literature review was done, comparing the results of several previous studies published in international scientific journals, about mineral disturbances in ESRD patients undergoing hemodialysis, among different countries in the world. In all mentioned studies blood samples were taken from patients pre and post dialysis, measuring minerals by atomic absorption spectroscopy.
Results
The included studies obtained conflicting results, as some of them showed an increase in some minerals levels in post dialysis patients compared to pre dialysis, like (Zn, Cr), while other studies revealed a decrease in minerals post dialysis, like Mg, whereas, others found no significant differences between pre and post dialysis, like (Cu, Se). This contradiction may be due to the country of the study, environmental pollution, nutritional conditions, as well as, the conditions of hemodialysis, such as the composition of dialysis fluid, which is affected by the source of its water, and its content of minerals. The type of used dialysis membrane and its surface area also have effect on the movement of minerals through it, between the blood and the dialysis fluid.
Conclusion
In order to avoid the disturbances in serum minerals concentrations in ESRD patients, they should be regularly measured pre and post dialysis, doing the appropriate therapeutic procedures, in addition to best controlling of hemodialysis conditions, especially, the mineral content of hemodialysis fluid, in order to keep their balance in patients’ blood.
期刊介绍:
The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.
The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal''s scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.